L-NAME and l-arginine differentially ameliorate cigarette smoke-induced emphysema in mice

Pulmonary Pharmacology and Therapeutics

Volumn 24, Issue 5, 2011, Pages 587-594

  Valença, Samuel Santos ^a   Rueff Barroso, Carlos Romualdo ^b   Pimenta, Wagner Alves ^b   Melo, Adriana Correa ^a,b   Nesi, Renata Tiscoski ^a,b   Silva, Marco Aurélio Santos ^b   Porto, Luís Cristóvão ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cigarette smoke; Inflammation; Mouse; Nitric oxide; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ARGININE; N(G) NITROARGININE METHYL ESTER; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMICAL COMPOSITION; CIGARETTE SMOKING; CONTROLLED STUDY; HISTOPATHOLOGY; LUNG EMPHYSEMA; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; WESTERN BLOTTING;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; ARGININE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OXIDANTS; OXIDATIVE STRESS; PULMONARY EMPHYSEMA; SMOKE; SMOKING; TOBACCO;

EID: 80052424406     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2011.05.006     Document Type: Article

References (53)

1. Gately I. La Diva Nicotina. The history of how tobacco seduced the world 2001, Simon and Schuster, London.
2. Musk A.W., de Klerk N.H. History of tobacco and health. Respirology 2003, 8:286-290.
3. Heiman R.K. Tobacco and Americans 1960, McGraw-Hill, New York.
4. Viegi G., Scognamiglio A., Baldacci S., Pistelli F., Carrozzi L. Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 2001, 68:4-19.
5. Chung K.F., Adcock I.M. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008, 31:1334-1356.
6. WHO World Health Organization - world health report 2008.
7. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997, 349:1498-1504.
8. Rahman I., Biswas S.K., Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur. J. Pharmacol. 2006, 533:222-239.
9. Rahman I., Skwarska E., Henry M., Davis M., O'Connor C.M., FitzGerald M.X., et al. Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis. Free Radical Biol Med 1999, 27:60-68.
10. van der Vliet A., Eiserich J.P., Cross C.E. Nitric oxide: a pro-inflammatory mediator in lung disease?. Respir Res 2000, 1:67-72.
11. Tinker A.C., Wallace A.V. Selective inhibitors of inducible nitric oxide synthase: potential agents for the treatment of inflammatory diseases?. Curr Top Med Chem 2006, 6:77-92.
12. Valenca S.S., Pimenta W.A., Rueff-Barroso C.R., Ferreira T.S., Resende A.C., Moura R.S., et al. Involvement of nitric oxide in acute lung inflammation induced by cigarette smoke in the mouse. Nitric Oxide 2009, 20:175-181.
13. Rubio M.L., Martin-Mosquero M.C., Ortega M., Peces-Barba G., Gonzalez-Mangado N. Oral N-acetylcysteine attenuates elastase-induced pulmonary emphysema in rats. Chest 2004, 125:1500-1506.
14. Valenca S.S., Porto L.C. Immunohistochemical study of lung remodeling in mice exposed to cigarette smoke*. J Bras Pneumol 2008, 34:787-795.
15. 2-induced lung injury in rats. Eur Respir J 1995, 8:1115-1121.
16. Bannister J.V., Bannister W.H., Rotilio G. Aspects of the structure, function, and applications of superoxide dismutase. CRC Crit Rev Biochem 1987, 22:111-180.
17. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-126.
18. Suzuki K., Ota H., Sasagawa S., Sakatani T., Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983, 132:345-352.
19. Rahman I., Kode A., Biswas S.K. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat Protoc 2006, 1:3159-3165.
20. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982, 126:131-138.
21. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
22. Kirkham P., Rahman I. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 2006, 111:476-494.
23. Rahman I., Kilty I. Antioxidant therapeutic targets in COPD. Curr Drug Targets 2006, 7:707-720.
24. Barnes P.J. Future treatments for chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc 2008, 5:857-864.
25. de Boer W.I., Yao H., Rahman I. Future therapeutic treatment of COPD: struggle between oxidants and cytokines. Int J Chron Obstruct Pulmon Dis 2007, 2:205-228.
26. Owen C.A. Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2005, 2:373-385. discussion 94-5.
27. Boyer L., Plantier L., Dagouassat M., Lanone S., Goven D., Caramelle P., et al. Role of nitric oxide synthases in elastase-induced emphysema. Lab Invest 2011, 91:353-362.
28. Roh G.S., Yi C.O., Cho Y.J., Jeon B.T., Nizamudtinova I.T., Kim H.J., et al. Anti-inflammatory effects of celecoxib in rat lungs with smoke-induced emphysema. Am J Physiol Lung Cell Mol Physiol 2010, 299:L184-L191.
29. Atochina-Vasserman E.N., Beers M.F., Kadire H., Tomer Y., Inch A., Scott P., et al. Selective inhibition of inducible NO synthase activity in vivo reverses inflammatory abnormalities in surfactant protein D-deficient mice. J Immunol 2007, 179:8090-8097.
30. Atochina E.N., Beers M.F., Hawgood S., Poulain F., Davis C., Fusaro T., et al. Surfactant protein-D, a mediator of innate lung immunity, alters the products of nitric oxide metabolism. Am J Respir Cell Mol Biol 2004, 30:271-279.
31. Adams H.R. Physiologic, pathophysiologic, and therapeutic implications for endogenous nitric oxide. J Am Vet Med Assoc 1996, 209:1297-1302.
32. Cai S., Chen P., Zhang C., Chen J.B., Wu J. Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats. Respirology 2009, 14:354-359.
33. Dekhuijzen P.N., van Beurden W.J. The role for N-acetylcysteine in the management of COPD. Int J Chron Obstruct Pulmon Dis 2006, 1:99-106.
34. Sadowska A.M., Verbraecken J., Darquennes K., De Backer W.A. Role of N-acetylcysteine in the management of COPD. Int J Chron Obstruct Pulmon Dis 2006, 1:425-434.
35. Stav D., Raz M. Effect of N-acetylcysteine on air trapping in COPD: a randomized placebo-controlled study. Chest 2009, 136:381-386.
36. Yoshino K., Sano M., Hagiwara M., Fujita M., Tomita I. Accumulation of (E)-4-hydroxy-2-nonenal and n-hexanal, degradation products of lipid peroxides, in mouse lung and liver. Biol Pharmal Bull 1993, 16:84-86.
37. Vanderbist F., Maes P., Neve J. In vitro comparative assessment of the antioxidant activity of nacystelyn against three reactive oxygen species. Arzneimittelforschung 1996, 46:783-788.
38. De Backer W.A., Amsel B., Jorens P.G., Bossaert L., Hiemstra P.S., van Noort P., et al. N-acetylcysteine pretreatment of cardiac surgery patients influences plasma neutrophil elastase and neutrophil influx in bronchoalveolar lavage fluid. Intensive Care Med 1996, 22:900-908.
39. Shapiro S.D., Goldstein N.M., Houghton A.M., Kobayashi D.K., Kelley D., Belaaouaj A. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol 2003, 163:2329-2335.
40. Fridovich I. Superoxide dismutases. Annu Rev Biochem 1975, 44:147-159.
41. Ghezzi P., Bonetto V., Fratelli M. Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation. Antioxid Redox Signal 2005, 7:964-972.
42. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990, 87:1620-1624.
43. O'Donnel V.B., Freeman B.A. Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease. Circulation 2001, 88:12-21.
44. Oeckler R.A., Wolin M.S. New concepts in vascular nitric oxide signaling. Curr Atheroscler Rep 2000, 2:437-444.
45. Belvisi M.G., Stretton C.D., Yacoub M., Barnes P.J. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur J Pharmacol 1992, 210:221-222.
46. Ward J.K., Belvisi M.G., Fox A.J., Miura M., Tadjkarimi S., Yacoub M.H., et al. Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro. J Clin Invest 1993, 92:736-742.
47. Shujaat A., Minkin R., Eden E. Pulmonary hypertension and chronic cor pulmonale in COPD. Int J Chron Obstruct Pulmon Dis 2007, 2:273-282.
48. McGhan R., Radcliff T., Fish R., Sutherland E.R., Welsh C., Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007, 132:1748-1755.
49. MacMicking J.D., North R.J., LaCourse R., Mudgett J.S., Shah S.K., Nathan C.F. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci U S A 1997, 94:5243-5248.
50. Noda S., Tanaka K., Sawamura S., Sasaki M., Matsumoto T., Mikami K., et al. Role of nitric oxide synthase type 2 in acute infection with murine cytomegalovirus. J Immunol 2001, 166:3533-3541.
51. De Serres G., Lampron N., La Forge J., Rouleau I., Bourbeau J., Weiss K., et al. Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations. J Clin Virol 2009, 46:129-133.
52. Pryor W.A., Prier D.G., Church D.F. Electron-spin resonance study of mainstream and sidestream cigarette smoke: nature of the free radicals in gas-phase smoke and in cigarette tar. Environ Health Perspect 1983, 47:345-355.
53. Hatzinikolaou D.G., Lagesson V., Stavridou A.J., Pouli A.E., Lagesson-Andrasko L., Stavrides J.C. Analysis of the gas phase of cigarette smoke by gas chromatography coupled with UV-diode array detection. Anal Chem 2006, 78:4509-4516.